Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0514 Transporter Info
Gene Name	ANXA11
Transporter Name	Annexin A11
Gene ID	311
UniProt ID	P50995

Post-Translational Modification of This DT
Overview of ANXA11 Modification Sites with Functional and Structural Information
Sequence	M S Y P G Y P P P P G G Y P P A A P G G G P W G G A A Y P P P P S M P P I G L D N V A T Y A G Q F N Q D Y L S G M A A N M S G T F G G A N M P N L Y P G A P G A G Y P P V P P G G F G Q P P S A Q Q P V P P Y G M Y P P P G G N P P S R M P S Y P P Y P G A P V P G Q P M P P P G Q Q P P G A Y P G Q P P V T Y P G Q P P V P L P G Q Q Q P V P S Y P G Y P G S G T V T P A V P P T Q F G S R G T I T D A P G F D P L R D A E V L R K A M K G F G T D E Q A I I D C L G S R S N K Q R Q Q I L L S F K T A Y G K D L I K D L K S E L S G N F E K T I L A L M K T P V L F D I Y E I K E A I K G V G T D E A C L I E I L A S R S N E H I R E L N R A Y K A E F K K T L E E A I R S D T S G H F Q R L L I S L S Q G N R D E S T N V D M S L A Q R D A Q E L Y A A G E N R L G T D E S K F N A V L C S R S R A H L V A V F N E Y Q R M T G R D I E K S I C R E M S G D L E E G M L A V V K C L K N T P A F F A E R L N K A M R G A G T K D R T L I R I M V S R S E T D L L D I R S E Y K R M Y G K S L Y H D I S G D T S G D Y R K I L L K I C G G N D
PTM type	X-Acetylation X-Malonylation X-Oxidation X-Phosphorylation X-S-nitrosylation X-S-sulfenylation X-S-sulfhydration X-Sulfoxidation X-SUMOylation X-Ubiquitination X: Amino Acid

Acetylation
Alanine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ANXA11			[1]
Role of PTM	Potential impacts
Modified Residue	Alanine	Modified Location	222
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at ANXA11 Alanine 222 has the potential to affect its expression or activity.
Glycine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ANXA11			[1]
Role of PTM	Potential impacts
Modified Residue	Glycine	Modified Location	215
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at ANXA11 Glycine 215 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ANXA11			[1]
Role of PTM	Potential impacts
Modified Residue	Glycine	Modified Location	446
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at ANXA11 Glycine 446 has the potential to affect its expression or activity.
Lysine	8 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ANXA11			[2]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	243
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at ANXA11 Lysine 243 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ANXA11			[1]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	248
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at ANXA11 Lysine 248 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence ANXA11			[1]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	255
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at ANXA11 Lysine 255 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence ANXA11			[3]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	282
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at ANXA11 Lysine 282 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence ANXA11			[2] , [4]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	315
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at ANXA11 Lysine 315 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence ANXA11			[2] , [4]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	378
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at ANXA11 Lysine 378 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence ANXA11			[4] , [5]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	408
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at ANXA11 Lysine 408 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence ANXA11			[1]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	479
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at ANXA11 Lysine 479 has the potential to affect its expression or activity.
Malonylation
Lysine	5 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ANXA11			[6]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	248
Experimental Method	Co-Immunoprecipitation
Detailed Description	Malonylation at ANXA11 Lysine 248 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ANXA11			[6]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	252
Experimental Method	Co-Immunoprecipitation
Detailed Description	Malonylation at ANXA11 Lysine 252 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence ANXA11			[6]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	255
Experimental Method	Co-Immunoprecipitation
Detailed Description	Malonylation at ANXA11 Lysine 255 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence ANXA11			[6]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	315
Experimental Method	Co-Immunoprecipitation
Detailed Description	Malonylation at ANXA11 Lysine 315 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence ANXA11			[6]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	320
Experimental Method	Co-Immunoprecipitation
Detailed Description	Malonylation at ANXA11 Lysine 320 has the potential to affect its expression or activity.
Oxidation
Cystine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ANXA11			[7]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	226
Experimental Method	Co-Immunoprecipitation
Detailed Description	Oxidation at ANXA11 Cystine 226 has the potential to affect its expression or activity.
Phosphorylation
Serine	15 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ANXA11			[8]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	231
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA11 Serine 231 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ANXA11			[8] , [9]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	241
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA11 Serine 241 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence ANXA11			[10]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	259
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA11 Serine 259 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence ANXA11			[11] , [12]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	301
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA11 Serine 301 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence ANXA11			[11] , [12]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	303
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA11 Serine 303 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence ANXA11			[10] , [13]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	340
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA11 Serine 340 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence ANXA11			[10] , [13]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	342
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA11 Serine 342 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence ANXA11			[14]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	377
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA11 Serine 377 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence ANXA11			[10]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	415
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA11 Serine 415 has the potential to affect its expression or activity.
PTM Phenomenon 10	Have the potential to influence ANXA11			[15] , [16]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	460
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA11 Serine 460 has the potential to affect its expression or activity.
PTM Phenomenon 11	Have the potential to influence ANXA11			[15] , [16]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	462
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA11 Serine 462 has the potential to affect its expression or activity.
PTM Phenomenon 12	Have the potential to influence ANXA11			[15]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	471
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA11 Serine 471 has the potential to affect its expression or activity.
PTM Phenomenon 13	Have the potential to influence ANXA11			[17] , [18]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	480
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA11 Serine 480 has the potential to affect its expression or activity.
PTM Phenomenon 14	Have the potential to influence ANXA11			[17]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	486
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA11 Serine 486 has the potential to affect its expression or activity.
PTM Phenomenon 15	Have the potential to influence ANXA11			[17]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	490
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA11 Serine 490 has the potential to affect its expression or activity.
Threonine	7 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ANXA11			[19]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	272
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA11 Threonine 272 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ANXA11			[12]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	290
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA11 Threonine 290 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence ANXA11			[11] , [20]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	321
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA11 Threonine 321 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence ANXA11			[14]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	374
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA11 Threonine 374 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence ANXA11			[21]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	402
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA11 Threonine 402 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence ANXA11			[22]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	464
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA11 Threonine 464 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence ANXA11			[17] , [23]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	489
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA11 Threonine 489 has the potential to affect its expression or activity.
Tyrosine	8 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ANXA11			[19]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	53
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA11 Tyrosine 53 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ANXA11			[13] , [24]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	279
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA11 Tyrosine 279 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence ANXA11			[11]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	314
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA11 Tyrosine 314 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence ANXA11			[25] , [26]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	365
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA11 Tyrosine 365 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence ANXA11			[17] , [21]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	398
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA11 Tyrosine 398 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence ANXA11			[15]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	473
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA11 Tyrosine 473 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence ANXA11			[17] , [24]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	482
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA11 Tyrosine 482 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence ANXA11			[17] , [27]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	493
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA11 Tyrosine 493 has the potential to affect its expression or activity.
S-nitrosylation
Cystine	4 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ANXA11			[28] , [29]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	226
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-nitrosylation (-SNO) at ANXA11 Cystine 226 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ANXA11			[30] , [31]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	294
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-nitrosylation at ANXA11 Cystine 294 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence ANXA11			[31] , [32]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	384
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-nitrosylation at ANXA11 Cystine 384 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence ANXA11			[32]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	428
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-nitrosylation at ANXA11 Cystine 428 has the potential to affect its expression or activity.
S-sulfenylation
Cystine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ANXA11			[33]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	384
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-sulfenylation (-SOH) at ANXA11 Cystine 384 has the potential to affect its expression or activity.
S-sulfhydration
Cystine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ANXA11			[34] , [35]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	294
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-sulfhydration (-SSH) at ANXA11 Cystine 294 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ANXA11			[35]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	384
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-sulfhydration (-SSH) at ANXA11 Cystine 384 has the potential to affect its expression or activity.
Sulfoxidation
Methionine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ANXA11			[36] , [37]
Role of PTM	Potential impacts
Modified Residue	Methionine	Modified Location	354
Experimental Method	Co-Immunoprecipitation
Detailed Description	Sulfoxidation at ANXA11 Methionine 354 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ANXA11			[37]
Role of PTM	Potential impacts
Modified Residue	Methionine	Modified Location	414
Experimental Method	Co-Immunoprecipitation
Detailed Description	Sulfoxidation at ANXA11 Methionine 414 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence ANXA11			[37]
Role of PTM	Potential impacts
Modified Residue	Methionine	Modified Location	422
Experimental Method	Co-Immunoprecipitation
Detailed Description	Sulfoxidation at ANXA11 Methionine 422 has the potential to affect its expression or activity.
SUMOylation
Lysine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ANXA11			[1]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	255
Experimental Method	Co-Immunoprecipitation
Detailed Description	Sumoylation at ANXA11 Lysine 255 has the potential to affect its expression or activity.
Ubiquitination
Arginine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ANXA11			[38] , [39]
Role of PTM	Potential impacts
Modified Residue	Arginine	Modified Location	371
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ANXA11 Arginine 371 has the potential to affect its expression or activity.
Leucine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ANXA11			[38] , [39]
Role of PTM	Potential impacts
Modified Residue	Leucine	Modified Location	364
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ANXA11 Leucine 364 has the potential to affect its expression or activity.
Lysine	7 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ANXA11			[1]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	248
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ANXA11 Lysine 248 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ANXA11			[39]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	252
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ANXA11 Lysine 252 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence ANXA11			[1]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	255
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ANXA11 Lysine 255 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence ANXA11			[38]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	264
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ANXA11 Lysine 264 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence ANXA11			[39]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	271
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ANXA11 Lysine 271 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence ANXA11			[40]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	282
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ANXA11 Lysine 282 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence ANXA11			[1]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	479
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ANXA11 Lysine 479 has the potential to affect its expression or activity.
Serine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ANXA11			[38] , [39]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	231
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ANXA11 Serine 231 has the potential to affect its expression or activity.
Valine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ANXA11			[38] , [39]
Role of PTM	Potential impacts
Modified Residue	Valine	Modified Location	352
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ANXA11 Valine 352 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ANXA11			[38] , [39]
Role of PTM	Potential impacts
Modified Residue	Valine	Modified Location	382
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ANXA11 Valine 382 has the potential to affect its expression or activity.

References
1	Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science. 2009 Aug 14;325(5942):834-40.
2	Deep, Quantitative Coverage of the Lysine Acetylome Using Novel Anti-acetyl-lysine Antibodies and an Optimized Proteomic Workflow. Mol Cell Proteomics. 2015 Sep;14(9):2429-40.
3	Lysine succinylation is a frequently occurring modification in prokaryotes and eukaryotes and extensively overlaps with acetylation. Cell Rep. 2013 Aug 29;4(4):842-51.
4	Quantitative Proteomic Atlas of Ubiquitination and Acetylation in the DNA Damage Response. Mol Cell. 2015 Sep 3;59(5):867-81.
5	Lysine Acetylation and Succinylation in HeLa Cells and their Essential Roles in Response to UV-induced Stress. Sci Rep. 2016 Jul 25;6:30212.
6	Proteomic and Biochemical Studies of Lysine Malonylation Suggest Its Malonic Aciduria-associated Regulatory Role in Mitochondrial Function and Fatty Acid Oxidation. Mol Cell Proteomics. 2015 Nov;14(11):3056-71.
7	A Quantitative Tissue-Specific Landscape of Protein Redox Regulation during Aging. Cell. 2020 Mar 5;180(5):968-983.e24.
8	Phosphoproteomic and Functional Analyses Reveal Sperm-specific Protein Changes Downstream of Kappa Opioid Receptor in Human Spermatozoa. Mol Cell Proteomics. 2019 Mar 15;18(Suppl 1):S118-S131.
9	Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
10	Proteogenomics connects somatic mutations to signalling in breast cancer. Nature. 2016 Jun 2;534(7605):55-62.
11	An Augmented Multiple-Protease-Based Human Phosphopeptide Atlas. Cell Rep. 2015 Jun 23;11(11):1834-43.
12	Reactive Oxygen Species (ROS)-Activated ATM-Dependent Phosphorylation of Cytoplasmic Substrates Identified by Large-Scale Phosphoproteomics Screen. Mol Cell Proteomics. 2016 Mar;15(3):1032-47.
13	Proteogenomic integration reveals therapeutic targets in breast cancer xenografts. Nat Commun. 2017 Mar 28;8:14864.
14	Targeting CDK2 overcomes melanoma resistance against BRAF and Hsp90 inhibitors. Mol Syst Biol. 2018 Mar 5;14(3):e7858.
15	Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci Signal. 2010 Jan 12;3(104):ra3.
16	Global detection of protein kinase D-dependent phosphorylation events in nocodazole-treated human cells. Mol Cell Proteomics. 2012 May;11(5):160-70.
17	Deep Phosphotyrosine Proteomics by Optimization of Phosphotyrosine Enrichment and MS/MS Parameters. J Proteome Res. 2017 Feb 3;16(2):1077-1086.
18	Spectrum of complications in chronic kidney disease patients undergoing maintenance hemodialysis: An experience of a tertiary care center in Nepal. Saudi J Kidney Dis Transpl. 2019 Jan-Feb;30(1):208-214.
19	dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: ANX11_HUMAN)
20	Comment on Eschweiler et al. Anatomy, Biomechanics, and Loads of the Wrist Joint. Life 2022, 12, 188. Life (Basel). 2022 Jul 31;12(8):1166.
21	Cdc7-Dbf4-mediated phosphorylation of HSP90-S164 stabilizes HSP90-HCLK2-MRN complex to enhance ATR/ATM signaling that overcomes replication stress in cancer. Sci Rep. 2017 Dec 5;7(1):17024.
22	Quantitative phosphoproteomics identifies substrates and functional modules of Aurora and Polo-like kinase activities in mitotic cells. Sci Signal. 2011 Jun 28;4(179):rs5.
23	Phytochemical and antitumor studies on Cynanchum mongolicum (Maxim.) Kom. Nat Prod Res. 2020 Dec;34(24):3437-3443.
24	HSP90 promotes Burkitt lymphoma cell survival by maintaining tonic B-cell receptor signaling. Blood. 2017 Feb 2;129(5):598-608.
25	Ultra-deep tyrosine phosphoproteomics enabled by a phosphotyrosine superbinder. Nat Chem Biol. 2016 Nov;12(11):959-966.
26	Wide-scale quantitative phosphoproteomic analysis reveals that cold treatment of T cells closely mimics soluble antibody stimulation. J Proteome Res. 2015 May 1;14(5):2082-9.
27	The first Canadian pediatric case of extensively drug-resistant Salmonella Typhi originating from an outbreak in Pakistan and its implication for empiric antimicrobial choices. IDCases. 2019 Jan 15;15:e00492.
28	Dual Labeling Biotin Switch Assay to Reduce Bias Derived From Different Cysteine Subpopulations: A Method to Maximize S-Nitrosylation Detection. Circ Res. 2015 Oct 23;117(10):846-57.
29	Proteome-wide detection of S-nitrosylation targets and motifs using bioorthogonal cleavable-linker-based enrichment and switch technique. Nat Commun. 2019 May 16;10(1):2195.
30	Predict and analyze S-nitrosylation modification sites with the mRMR and IFS approaches. J Proteomics. 2012 Feb 16;75(5):1654-65.
31	Proteomic analysis of S-nitrosylation and denitrosylation by resin-assisted capture. Nat Biotechnol. 2009 Jun;27(6):557-9.
32	Protein microarray characterization of the S-nitrosoproteome. Mol Cell Proteomics. 2014 Jan;13(1):63-72.
33	Proteome-Wide Analysis of Cysteine S-Sulfenylation Using a Benzothiazine-Based Probe. Curr Protoc Protein Sci. 2019 Feb;95(1):e76.
34	Site-Specific Quantification of Persulfidome by Combining an Isotope-Coded Affinity Tag with Strong Cation-Exchange-Based Fractionation. Anal Chem. 2019 Dec 3;91(23):14860-14864.
35	Direct Proteomic Mapping of Cysteine Persulfidation. Antioxid Redox Signal. 2020 Nov 20;33(15):1061-1076.
36	Redox proteomics of protein-bound methionine oxidation. Mol Cell Proteomics. 2011 May;10(5):M110.006866.
37	Global analysis of methionine oxidation provides a census of folding stabilities for the human proteome. Proc Natl Acad Sci U S A. 2019 Mar 26;116(13):6081-6090.
38	A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles. Mol Cell Proteomics. 2011 Oct;10(10):M111.013284.
39	Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell. 2011 Oct 21;44(2):325-40.
40	New findings on essential amino acids. Cesk Fysiol. 1990;39(1):13-25.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence